ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Insight Advisors LLC PA

Insight Advisors LLC PA cut its stake in ARK Genomic Revolution ETF (BATS:ARKG) by 17.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,237 shares of the company’s stock after selling 2,996 shares during the period. Insight Advisors LLC PA’s holdings in ARK Genomic Revolution ETF were worth $338,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Union Bancaire Privee UBP SA purchased a new stake in shares of ARK Genomic Revolution ETF during the 4th quarter worth $45,000. National Bank of Canada FI raised its stake in ARK Genomic Revolution ETF by 28.4% in the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after buying an additional 920 shares in the last quarter. IHT Wealth Management LLC purchased a new stake in ARK Genomic Revolution ETF during the 3rd quarter worth about $203,000. Sanctuary Advisors LLC acquired a new position in shares of ARK Genomic Revolution ETF during the 2nd quarter worth about $222,000. Finally, Hilltop Holdings Inc. purchased a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at about $237,000.

ARK Genomic Revolution ETF Trading Up 15.8 %

Shares of BATS ARKG opened at $27.34 on Friday. The stock’s fifty day simple moving average is $25.40 and its 200-day simple moving average is $25.23.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.